PT-141 (Bremelanotide) · Research brief
Buy PT141 — What to Check Before You Order
Short answer
Most sourcing failures don't happen at the bench. They happen on the label. A vial stamped 10mg can hold noticeably less actual peptide than 10mg, because gross fill weight includes counterion salt and residual moisture, and nothing on the outside of the container tells you which figure you're reading.
Key takeaways
- The most useful question to ask before you buy PT141 is whether the stated milligram figure is net peptide content or gross vial weight, because gross weight includes counterion salt and residual water.
- HPLC purity tells you how much of the sample is the main peak; mass spectrometry is what confirms the powder is bremelanotide, and purity without identity describes an unknown.
- PT141 is bremelanotide, a cyclic heptapeptide melanocortin receptor agonist modelled on alpha-MSH, with published research interest concentrated on MC4R signalling.
- Research-grade PT141 is not FDA-approved and is not the same product as the approved bremelanotide prescription injection, even though the active molecule is identical.
- A certificate with no lot number matching your vial documents a supplier's process rather than your material, which is why labs that buy PT141 for repeatable work insist on lot-matched paperwork.
- Lyophilized powder is considerably more stable than reconstituted solution, which is why dry vials ship without dry ice while solutions are refrigerated and used over a short period.
- Peptide powder is hygroscopic, so opening a cold vial in humid air can begin hydrolysis before a single measurement is taken.
Most sourcing failures don't happen at the bench. They happen on the label. A vial stamped 10mg can hold noticeably less actual peptide than 10mg, because gross fill weight includes counterion salt and residual moisture, and nothing on the outside of the container tells you which figure you're reading.
We synthesize in small batches and document every lot, so we see this pattern constantly: two vials, identical stated milligrams, different real content. If you want to buy PT141 for laboratory research, the decision is less about price per vial than about what the paperwork can prove.
Where can you buy PT141 for research use?
You can buy PT141 (bremelanotide) from research-grade peptide suppliers that publish lot-specific certificates of analysis showing HPLC purity and mass spectrometry identity. PT141 ships as a lyophilized powder for laboratory research only. The strongest suppliers state net peptide content rather than gross vial weight.
The usual oversimplification is that a purity percentage settles the question. It doesn't. A sample can run high on purity by HPLC and still be the wrong sequence if nobody ran mass spec, and the correct sequence at gross weight still leaves every downstream concentration calculated against the wrong denominator. Before you buy PT141, three things matter: what bremelanotide is at the molecular level, which documents actually prove identity, and how storage decides whether the compound survives to the experiment.
What bremelanotide actually is at the molecular level
PT141 is bremelanotide, a synthetic cyclic heptapeptide modelled on alpha-MSH (alpha-melanocyte-stimulating hormone), the endogenous ligand family that activates melanocortin receptors. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, and the cyclisation is the whole point. Closing the ring through a lactam bridge locks the pharmacophore into a conformation that resists the enzymatic breakdown a linear analog wouldn't survive.
Mechanistically it's a melanocortin receptor agonist, with published research attention centred largely on MC4R (the melanocortin-4 receptor), which is expressed in the central nervous system. That's a different pathway from PDE5 inhibitors such as sildenafil, which act peripherally on vascular smooth muscle. Anyone about to buy PT141 should know that distinction, because the melanocortin literature spans appetite regulation, inflammatory signalling and central pathways well beyond the single indication most people associate with the molecule.
One regulatory point matters more than any marketing line. Bremelanotide is the active ingredient in an approved prescription injection, but research-grade PT141 supplied as lyophilized powder is not that drug product and is not FDA-approved for any use. The molecule is the same. The finished, sterile, tested, labelled pharmaceutical is not. Researchers who buy PT141 for receptor or pathway work are buying a chemical reagent, full stop.
In our experience that's the most misunderstood idea in this whole category: people assume approval of a drug product transfers to the raw compound. It doesn't, and no legitimate supplier will tell you otherwise.
What to verify before you buy PT141
Three documents settle most of it: a lot-specific certificate of analysis, an HPLC chromatogram, and a mass spectrum. HPLC (high-performance liquid chromatography) reports purity as an area percentage, meaning how much of what's in the vial is the main peak rather than truncated sequences, deletion impurities or process residues. Mass spectrometry supplies identity by matching measured mass against the expected mass for the sequence. Purity without identity is just a number describing an unknown.
Then the part most listings skip. Net peptide content is not gross vial weight. After purification many peptides carry a trifluoroacetate (TFA) counterion, and lyophilized powder retains some residual water, so the mass in the vial includes material that isn't peptide. A vial can be honestly labelled and still hold less peptide than the number printed on it. Amino acid analysis or nitrogen determination on the certificate resolves this. Silence on the certificate does not.
Here's the error we see most often, and it isn't contamination. It's a lab treating gross weight as net, then building an entire concentration series on that denominator. Purity looked fine. Identity was correct. Every data point shifted by the same invisible margin, consistently enough that nobody questioned it.
Salt form deserves a question too, since TFA and acetate forms behave differently in some cell-based assays. When you buy PT141 from a supplier who can't name the salt form, you've accepted an uncontrolled variable. Labs that buy PT141 repeatedly for quantitative work learn to ask first.
Storage, cold chain, and the arithmetic on the vial
Lyophilized peptides are stable enough in dry form to survive transit without dry ice. Solutions are not. That asymmetry is why research peptides arrive as powder rather than premixed. General laboratory practice for long-term storage of lyophilized peptide is freezer storage at roughly minus 20 degrees Celsius or colder, protected from light and moisture, with reconstituted material refrigerated at 2 to 8 degrees Celsius and used over a short window rather than held for months.
After you buy PT141, the first thing worth recording is arrival date and condition. A handling detail costs people material more often than shipping does: let a cold vial equilibrate to room temperature before breaking the seal. Peptide powder is hygroscopic, and condensation forming on cold powder in humid air starts hydrolysis you can't see and can't reverse.
The arithmetic is simple once net content is known. If a certificate states 10mg of net peptide and 2mL of diluent is added, the solution is 5mg/mL. On a U-100 syringe, where 100 units equals 1mL, 10 units is 0.1mL, which works out to 0.5mg of peptide at that concentration. Those are illustrative figures for reading a label and a certificate, not a recommendation of any quantity for any purpose.
This is research framing throughout. These compounds are supplied for laboratory research only, never for human or animal consumption, and if the question behind your search concerns an animal's health, talk to your veterinarian rather than sourcing a research chemical. The information here is educational and describes laboratory documentation practice. The week you buy PT141 is rarely when handling errors surface. They surface a month later as drifting results.
Buy PT141: Supplier Type Comparison
Not every source that will sell you a vial can tell you what's inside it. This table compares the supplier categories researchers usually weigh when they buy PT141, and what each one typically documents.
| Supplier type | Documentation usually provided | Where the risk concentrates | Bottom line |
|---|---|---|---|
| Research-grade supplier with lot-specific COAs | Lot-matched HPLC chromatogram and mass spectrum, net peptide content, salt form, analysis date | Higher cost per vial; stock limited by small-batch synthesis runs | The right choice when data has to replicate across months, because any anomaly traces back to a documented batch. |
| Bulk overseas marketplace listing | One representative certificate reused across many listings, often undated and unmatched to lot | Sequence identity and salt form unverified; transit time and temperature uncontrolled | Usable only for rough non-quantitative screening; treat every concentration figure as an estimate. |
| Reseller repackaging third-party bulk | Own label, sometimes an original manufacturer certificate predating the repack | The fill and repack step is undocumented; net content may be copied rather than re-determined | Ask who performed the fill and when the certificate was issued; if nobody can answer, assume the label is nominal. |
| Social or forum-based seller | Screenshots and verbal assurance, no traceable lot number | No chain of custody, no analytical record, no recourse | Not appropriate for any research intended to be published or repeated. |
What If: Sourcing and Handling Scenarios
What if my vial arrived warm after four days in transit?
Log the excursion in your lab record before deciding anything. Lyophilized peptide tolerates ambient temperature far better than peptide in solution, which is exactly why research material ships dry, so a warm package is not automatically a ruined package. Inspect the cake, note the arrival condition, and for quantitative work ask the supplier for the stability position on that specific lot. A temperature history you cannot reconstruct is a data-integrity problem before it's a chemistry problem.
What if the certificate of analysis has no lot number matching my vial?
Treat the material as unverified until it does. A representative certificate tells you what a supplier's process produced at some point in the past, not what sits in the container on your bench. Anyone about to buy PT141 from a new source should request the lot-matched chromatogram and mass spectrum by lot number. Suppliers running genuine small-batch synthesis can produce both quickly, because those documents are generated per batch rather than per product page.
What if the powder looks like a thin film instead of a fluffy cake?
Don't assume degradation. Lyophilized cake appearance varies with fill volume, excipient-free formulation and the freeze-drying cycle used, and a thin glassy film at the bottom of a vial is common at low fill weights. What matters far more is evidence of moisture uptake: clumping, a syrupy look, or powder sticking to the vial wall. Those signs point to condensation or a compromised seal, and that is worth raising with the supplier before the vial is used.
What if the supplier can't say whether 10mg is net or gross?
Assume gross until documented otherwise, and compare prices on that basis. Gross weight can include trifluoroacetate counterion from reverse-phase purification plus residual water, so net peptide content is always the smaller figure. A certificate reporting peptide content by amino acid analysis or nitrogen determination removes the guesswork entirely. Labs that buy PT141 for concentration-dependent work tend to learn this the expensive way, usually after a study stops replicating.
The Unglamorous Truth About Peptide Sourcing
Here's the honest answer: price is the least informative number on any research peptide listing. Two vials can differ substantially in real peptide content while differing barely at all in advertised price, and only one of those gaps ever shows up in your data. Cheap compared to what? When you buy PT141, the only question that separates a usable source from a gamble is whether a human can send you the chromatogram for the lot number printed on your vial, today, without negotiation. Purity claims, slick packaging and fast checkout are decoration.
If you're comparing sources, our published certificates of analysis show what lot-level documentation should look like before you buy PT141 from anyone, and the wider research peptide catalog covers compounds like BPC-157 and Selank under the same small-batch synthesis and per-lot testing standard. Ordering and handling details sit on our locations page.
The researchers who buy PT141 and never run into trouble aren't luckier than everyone else. They've just narrowed what they accept as proof. A lot number that matches a chromatogram. A net content figure someone will put in writing. A storage condition recorded rather than assumed. Bremelanotide has been studied in the melanocortin literature for years, and none of that work replicates if the starting material is an unknown quantity in a labelled vial. The vial is the first variable in the experiment, not the last.
References
Peer-reviewed sources on PT-141 (Bremelanotide) indexed in PubMed, listed for research context. Real Peptides supplies PT-141 (Bremelanotide) for laboratory research use only.
- Small Effects, Questionable Outcomes: Bremelanotide for Hypoactive Sexual Desire Disorder. Journal of sex research, 2024. PMID 36809187. doi:10.1080/00224499.2023.2175192
- An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder. Expert opinion on pharmacotherapy, 2023. PMID 36242769. doi:10.1080/14656566.2022.2132144
- Bremelanotide for Treatment of Female Hypoactive Sexual Desire. Neurology international, 2022. PMID 35076581. doi:10.3390/neurolint14010006
- The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women. CNS spectrums, 2022. PMID 33455598. doi:10.1017/S109285292100002X
- Safety Profile of Bremelanotide Across the Clinical Development Program. Journal of women's health (2002), 2022. PMID 35147466. doi:10.1089/jwh.2021.0191
- Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide. Journal of women's health (2002), 2022. PMID 35230162. doi:10.1089/jwh.2021.0225
- Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in Women. Journal of sex research, 2021. PMID 33678061. doi:10.1080/00224499.2021.1885601
- Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedent. Drug and therapeutics bulletin, 2021. PMID 34642243. doi:10.1136/dtb.2021.000020
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA